Wilmslow, United Kingdom

Bohdan Waszkowycz


Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2001-2011

Loading Chart...
9 patents (USPTO):

Title: Bohdan Waszkowycz: A Visionary Inventor in the Technology Sector

Introduction:

Bohdan Waszkowycz, a visionary inventor based in Wilmslow, GB, is celebrated for his passion for innovation and relentless pursuit of excellence in the technology sector. His remarkable contributions continue to inspire and shape the landscape of technological advancements for future generations of inventors.

Latest Patents:

Bohdan Waszkowycz holds an impressive total of 9 patents, showcasing his expertise and creativity in the field of technology. Among his latest patents are "Meta-benzamidine derivatives as serine protease inhibitors" and "Serine protease inhibitors," which have significant implications in the realm of serine protease inhibitors and anti-inflammatory agents.

Career Highlights:

Throughout his illustrious career, Bohdan Waszkowycz has made significant strides in the technology sector. He has worked with esteemed companies such as Tularik Limited and Protherics Molecular Design Limited, where his innovative ideas have paved the way for groundbreaking developments in the industry.

Collaborations:

Bohdan Waszkowycz has had the privilege of collaborating with talented individuals in the field of technology, including coworkers such as Sarah Elizabeth Lively and Martin James Harrison. These collaborations have not only enhanced his own innovative abilities but have also led to the creation of impactful inventions and patents.

Conclusion:

Bohdan Waszkowycz's unwavering dedication to innovation and his visionary approach to invention have established him as a prominent figure in the technology sector. His contributions have left an indelible mark on the industry, inspiring a new wave of inventors to push the boundaries of technology and drive forward progress in the ever-evolving world of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…